VANDA PHARMAC.INC.DL-,001 financial statements, including revenue, expenses, profit, and loss
The total revenue of VM4 for the last quarter is 43.99 M EUR, and it's 7.24% higher compared to the previous quarter. The net income of Q1 24 is -3.84 M EUR.